Investors & Media

Press releases

Regeneron Science Talent Search 2026 Recognizes America’s Top Young Scientists, Awarding More Than $1.8 Million to High School Seniors for Innovative Research in Computational Mathematics, Neural Science, and Blood Cancer Treatment

Olatorepatide Obesity Treatment Licensed by Regeneron Demonstrates Positive Phase 3 Results in Chinese Patients

Regeneron Announces Investor Conference Presentation

Visit our newsroom

Upcoming & recent events

View investor events

Quarterly materials

Show all

Q4 2025

Market Cap:

Mar 21, 2026 1:44 PM EDT

Minimum 15 minutes delayed. Source: LSEG

Interactive analyst center

Interactive and downloadable financial data for investors and analysts.

View analyst center

Corporate responsibility

We're dedicated to responsible business practices, integrating the highest standards of integrity into every facet of our operations.

Learn about our approach to corporate responsibility

Contact us

Investors

914.847.7741

invest@regeneron.com

Media

media@regeneron.com

Sign up for email alerts

Regeneron corporate and R&D headquarters